Circulating Tumor Cell

This in-depth presentation explores Circulating Tumor Cells (CTCs)—cancer cells that break away from a primary tumor and circulate in the bloodstream, serving as critical indicators of metastasis and potential targets for early intervention. The presentation opens with a clear introduction to CTCs, followed by a historical discovery timeline and compelling facts and statistics that establish their clinical relevance. Audiences are guided through the biology of CTCs, followed by methods for detection and isolation of CTCs. CTCs are further explored as biomarkers for early detection, prognosis, and treatment customization, supported by findings from completed clinical trials.

A unique feature of this presentation is its integration of immunological context, with a focused discussion on the thymus—its structure, critical components, and the impact of aging and thymic involution on immune surveillance and cancer defense. Building on this, the presentation introduces Transfer Factor (TF). Backed by publications linking TF to tumor research, this segment offers a compelling look at how immune-enhancing biologics could complement CTC-targeted therapies. Authored by Prof. Dato’ Sri Dr. Mike Chan and supported by proprietary clinical experiences and original research, this presentation is ideal for oncologists, researchers, biomedical scientists, and integrative health professionals seeking advanced insights into the evolving landscape of cancer diagnosis, treatment, and immune-based strategies.